US 2026/0240925 A1 · METHOD AND COMPOSITION FOR PREVENTING OR TREATING MYOPIA

Abstract

An object of the present invention is to provide a method for preventing or treating myopia, and a composition used in said method. The present invention provides a method and composition for inhibiting, improving, or treating myopia by administering a substance that induces M2 macrophage polarization, a substance that regulates the function of choroid-resident immune cells, such as a mast cell stabilizer or a chemical mediator release inhibitor, or lactic acid bacteria. Regulating the function of choroid-resident immune cells, for example by inducing the polarization of M2 macrophages in the choroid or by administering a mast cell stabilizer, a chemical mediator release inhibitor, or lactic acid bacteria, is effective in myopia prevention and treatment.

Claims10

Dependent claims

A method for inhibiting, improving, or treating myopia, comprising administering to a subject in need thereof a therapeutically effective amount of a choroid-resident immune cell function regulator or lactic acid bacteria.

Dependencies are inferred from the claim text.

Facts

Application

18/859,459Filed 25 Apr 2023

Priority

JP 2022-07259626 Apr 2022

Published

20 Aug 2026

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 35/747
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs: lactobacilli, e.g. L. acidophilus or L. brevis
A23L 33/10
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof: using additives
A23L 33/135
Using additives: bacteria or derivatives thereof, e.g. probiotics
A23L 33/18
Amino acids, peptides or proteins: peptides; Protein hydrolysates

Method and composition for preventing or treating myopia

Life of this patent

Method and composition for preventing or treating myopia

Life of this patent

Abstract

Claims10